ARCHIVES

NCAB Committee To Propose Event Marking Cancer Act

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

ACCC Presentations On Care In Community

March 27, 1981

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997